StockData
BICXOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31

BioCorRx Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.25+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
$7.30M
P/E (TTM)
–
Dividend yield
–

BioCorRx Inc. balance sheet

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin
–
Operating margin
-614.8%
Net margin
-396.5%
Return on equity, FY2025
29.5%

Financial strength

Current ratio
0.07
Debt to equity
–
Debt to assets
–
Cash to current liabilities
0.2%

Valuation

P/E ratio
–
Price to sales
9.16
Price to book
–
Dividend yield
–